OCTANE study: switching from GLP-1 shots to the Wegovy pill added 4.1% weight loss
In 194 adults who moved from injectable semaglutide or tirzepatide to oral semaglutide, 40.7% lost at least 5% more in three months. Data shown at EASD, not yet peer reviewed.
Recap by typeshit. Full story at Healthline.